Clinical trial
Treosulfan-based Conditioning for Transplantation in AML/MDS
NCT00491634 · Dr. Avichai Shimoni MD, Other · Completed
Key facts
| NCT number | NCT00491634 |
|---|---|
| Title | Treosulfan-based Conditioning for Transplantation in AML/MDS |
| Official title | Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Chemo-refractory or Previously Untreated Acute Myeloid Leukemia and Myelodysplastic Syndrome. |
| Lead sponsor | Dr. Avichai Shimoni MD, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | treosulfan, Treosulfan |
| Enrollment | 24 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Jun 26, 2007 |
| Last update posted | Dec 2, 2015 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: